about
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationIn vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cellsSensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyDAMPs and PDT-mediated photo-oxidative stress: exploring the unknown.Immunogenic cell death and DAMPs in cancer therapy.Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.Classification of current anticancer immunotherapiesMolecular and Translational Classifications of DAMPs in Immunogenic Cell Death.PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stressResistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removalIrradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma.Danger signalling during cancer cell death: origins, plasticity and regulation.Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.Targeting ER stress induced apoptosis and inflammation in cancer.Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation.ER stress-induced inflammation: does it aid or impede disease progression?Inducers of immunogenic cancer cell death.Autophagy: shaping the tumor microenvironment and therapeutic response.Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer ImmunityER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses.Autophagy, a major adaptation pathway shaping cancer cell death and anticancer immunity responses following photodynamic therapy.The PERKs of damage-associated molecular patterns mediating cancer immunogenicity: From sensor to the plasma membrane and beyond.Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma.Immunogenic cell death.BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomas.Coordination of stress, Ca2+, and immunogenic signaling pathways by PERK at the endoplasmic reticulum.Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity.Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress.Transplantation and Damage-Associated Molecular Patterns (DAMPs).DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing.ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysisHypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin.Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality.EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research.Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing.Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.
P50
Q24620548-75D69CA0-62A8-4D53-8A27-AEF6CB15A06BQ28386858-FCABD57B-756D-4EA3-BD99-C57EB98FA0A1Q28482082-E8B44C65-E46F-4CDC-A33D-BFF68EBA1229Q33683101-1CF73475-0926-4D96-85D2-34DA462B91BDQ34160434-97233B5F-26E5-44B5-A7F6-EECEA972ECB5Q34311701-A47DA7CF-161E-4013-854F-55940EA14F1BQ35000446-152D15E5-3F3B-46FD-91AD-0A68945FD0C3Q35149637-BB260509-2BE8-4A5E-976B-7611D69AFC73Q36301061-85012231-FFBE-468D-BC25-24ED18EEDABFQ36311137-012B086B-9AA3-4FCF-A9D9-55E9C8A68DC8Q36413628-975F7157-DCCF-40D0-81B7-E3C7E86DF1DBQ36710917-5873D827-9FE6-4A48-8DA1-07D69B172615Q37381745-31C0C319-373E-4669-824C-BBEE62CC6874Q37707162-0E395BCD-49BD-45C2-B85C-0F8F1A5039D2Q37781924-116EBCDC-4BBF-44D5-9036-5A641B0203E3Q37844960-FCF9EFF9-DD14-420A-9620-87DAAEFE5261Q38033784-37486A9C-5872-4F3F-8F6A-EBED9B3D198DQ38079937-165FCED8-BDD3-4216-AA1A-455F73A338FAQ38110096-F143ADC8-1295-499D-B11C-637806197E7BQ38174601-6AD27042-097D-4779-B762-9DEF491995E4Q38184935-727DD95E-8607-4990-A738-7557215C40DEQ38349813-57A6DBCD-7E7C-4897-B86B-BA3F6039015AQ38424822-BEE64022-D395-4466-8BC9-252A026F5AC3Q38438763-C6342586-D520-4216-ABDB-7D431FB6735FQ38587698-8E86CF5A-3A03-43E7-B01E-30C19D2BFE78Q38593285-1F66195C-3096-4634-B88E-020307A5B594Q38671364-D47D5BB2-B07B-42B9-B5EC-D02D1D65DF95Q38708463-C52B0194-F738-42CC-83FB-586D78B12175Q38731279-31AEF9BB-FF79-4E40-A430-640471448507Q38780317-8B4A21DE-54E7-4258-9365-87B294C47B93Q38866745-AC3FCBB1-140B-47F5-BB8D-5F4936228A85Q38898214-EACA09A1-C498-42EC-9258-2CEC589052BEQ38928826-4AD0D0BC-23D2-459A-A33F-F37EDC4EB117Q39135022-3D1C2BDF-BB67-4B54-ABE6-DE3E13FB538AQ39281286-0E2AD011-54CF-41A3-9868-073740733951Q39423568-52538591-EDA1-4FB5-9F0E-80D9F101F35FQ39585070-85D9A2DE-39D4-4D21-B5C8-E7EAEC658A4FQ40314364-ADC14AAF-4470-4F1B-8712-FC9B71B5AB0FQ40319033-4D5F8EE1-9A36-4BE2-BCB8-3FCDDDD3B4F0Q41436818-1FB56F89-D12D-4580-9691-1D0D54BBF23F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Abhishek D. Garg
@ast
Abhishek D. Garg
@en
Abhishek D. Garg
@es
type
label
Abhishek D. Garg
@ast
Abhishek D. Garg
@en
Abhishek D. Garg
@es
prefLabel
Abhishek D. Garg
@ast
Abhishek D. Garg
@en
Abhishek D. Garg
@es
P1053
D-5230-2012
P106
P1153
35490172600
P1960
wxn33ksAAAAJ
P2038
Abhishek_Garg4
P21
P2798
P31
P3829
P3835
abhishek-garg8
P496
0000-0002-9976-9922